Referral and treatment patterns among patients with stages III and IV non-small-cell lung cancer

Journal of Oncology Practice

Volumn 9, Issue 1, 2013, Pages 42-50

  Goulart, Bernardo H L ^a   Reyes, Carolina M ^b   Fedorenko, Catherine R ^b   Mummy, David G ^b   Satram Hoang, Sacha ^b   Koepl, Lisel M ^b   Blough, David K ^b   Ramsey, Scott D ^b  

^a USA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; FEMALE; GENERAL PRACTITIONER; HUMAN; INCOME; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MEDICARE; MULTIMODALITY CANCER THERAPY; PATIENT CARE; PATIENT REFERRAL; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; TREATMENT INDICATION;

EID: 84877734163     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2012.000640     Document Type: Article

References (30)

1. Siegel R, Ward E, Brawley O, et al: Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236, 2011
2. Govindan R, Page N, Morgensztern D, et al: Changing epidemiology of smallcell lung cancer in the United States over the last 30 years: Analysis of the Surveillance, Epidemiologic, and End Results database. J Clin Oncol 24:4539- 4544, 2006
3. Nair A, Klusmann MJ, Jogeesvaran KH, et al: Revisions to the TNM staging of non-small cell lung cancer: Rationale, clinicoradiologic implications, and persistent limitations. Radiographics 31: 215-238, 2011
4. Albain KS, Swann RS, Rusch VW, et al: Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: A phase III randomised controlled trial. Lancet 374: 379-386, 2009
5. van Meerbeeck JP, Kramer GW, Van Schil PE, et al: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst 99: 442-450, 2007
6. Curran WJ Jr, Paulus R, Langer CJ, et al: Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: Randomized phase III trial RTOG 9410. J Natl Cancer Inst 103: 1452-1460, 2011
7. National Comprehensive Cancer Network: Non-Small Cell Lung Cancer version 2.2012, NCCN guidelines, NCCN, 2011. http://www.nccn.org
8. NSCLC Meta-Analyses Collaborative Group: Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: A systematic review and meta-analysis of individual patient data from 16 randomized controlled trials. J Clin Oncol 26: 4617-4625, 2008
9. Sandler A, Gray R, Perry MC, et al: Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 355: 2542-2550, 2006
10. Reck M, von Pawel J, Zatloukal P, et al: Overall survival with cisplatingemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: Results from a randomised phase III trial (AVAiL). Ann Oncol 21: 1804-1809, 2010
11. Shepherd FA, Rodrigues Pereira J, Ciuleanu T, et al: Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 353: 123-132, 2005
12. Earle CC, Neumann PJ, Gelber RD, et al: Impact of referral patterns on the use of chemotherapy for lung cancer. J Clin Oncol 20: 1786-1792, 2002
13. Beatty S, Stevens W, Stevens G, et al: Lung cancer patients in New Zealand initially present to secondary care through the emergency department rather than by referral to a respiratory specialist. N Z Med J 122: 33-41, 2009
14. Potosky AL, Riley GF, Lubitz JD, et al: Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 31: 732-748, 1993
15. National Cancer Institute: SEER program overview, National Cancer Institute, 2011. http://seer.cancer.gov/
16. Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45: 613-619, 1992
17. Hayman JA, Abrahamse PH, Lakhani I, et al: Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 69: 1001-1007, 2007
18. Warren JL, Harlan LC, Fahey A, et al: Utility of the SEER-Medicare data to identify chemotherapy use. Med Care 40: 55-61, 2002
19. Baldwin LM, Adamache W, Klabunde CN, et al: Linking physician characteristics and Medicare claims data: Issues in data availability, quality, and measurement. Med Care 40: 82-95, 2002
20. Jang TL, Bekelman JE, Liu Y, et al: Physician visits prior to treatment for clinically localized prostate cancer. Arch Intern Med 170: 440-450, 2010
21. Ramsey SD, Howlader N, Etzioni RD, et al: Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: Evidence from Surveillance, Epidemiology and End Results-Medicare. J Clin Oncol 22: 4971-4978, 2004
22. Li X, Butts C, Fenton D, et al: Utilization of oncology services and receipt of treatment: A comparison between patients with breast, colon, rectal, or lung cancer. Ann Oncol 22: 1902-1909, 2011
23. Podnos YD, Borneman TR, Koczywas M, et al: Symptom concerns and resource utilization in patients with lung cancer. J Palliat Med 10: 899-903, 2007
24. Vinod SK, O'Connell DL, Simonella L, et al: Gaps in optimal care for lung cancer. J Thorac Oncol 3: 871-879, 2008
25. Vinod SK, Simonella L, Goldsbury D, et al: Underutilization of radiotherapy for lung cancer in New South Wales, Australia. Cancer 116: 686-694, 2010
26. Wang J, Kuo YF, Freeman J, et al: Increasing access to medical oncology consultation in older patients with stage II-IIIA non-small-cell lung cancer. Med Oncol 25: 125-132, 2008
27. Winget M, Stanger J, Gao Z, et al: Predictors of surgery and consult with an oncologist for adjuvant chemotherapy in early stage NSCLC patients in Alberta, Canada. J Thorac Oncol 4: 629-634, 2009
28. Earle CC, Venditti LN, Neumann PJ, et al: Who gets chemotherapy for metastatic lung cancer? Chest 117: 1239-1246, 2000
29. Dalton SO, Frederiksen BL, Jacobsen E, et al: Socioeconomic position, stage of lung cancer and time between referral and diagnosis in Denmark, 2001- 2008. Br J Cancer 105: 1042-1048, 2011
30. Wassenaar TR, Eickhoff JC, Jarzemsky DR, et al: Differences in primary care clinicians' approach to non-small cell lung cancer patients compared with breast cancer. J Thorac Oncol 2: 722-728, 2007